GRANULES INDIA
Back to Cashflow Statement
|
GRANULES INDIA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹379 Cr | ₹-93 Cr | ₹7.66 Cr | ₹-440 Cr | ₹190 Cr |
What is the latest Cash Flow from Financing Activities ratio of GRANULES INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹379 Cr |
| Mar2025 | ₹-93 Cr |
| Mar2024 | ₹7.66 Cr |
| Mar2023 | ₹-440 Cr |
| Mar2022 | ₹190 Cr |
How is Cash Flow from Financing Activities of GRANULES INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹379 Cr | Positive | |
| Mar2025 | ₹-93 Cr | Negative | |
| Mar2024 | ₹7.66 Cr | Positive | |
| Mar2023 | ₹-440 Cr | Negative | |
| Mar2022 | ₹190 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,357.3 Cr | -1.7% | -3.3% | 48.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -1.7% |
-3.3% |
48.3% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses